Stocks
GlaxoSmithKline (GSK) Market cap US GAAP (year values)The current market cap of the company GlaxoSmithKline is 69 870 000 000 £. |
|||||||||
| 2022 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| Market cap, £ | 70 736 820 000 | 70 736 820 000 | 141 473 640 000 | 152 353 660 000 | 152 319 999 996 | 69 870 000 000 | |||
| Changes by years, y/y, % | +0% | 0% | +100% | +8% | 0% | +15.2% | |||
GlaxoSmithKline. Market cap, £
GlaxoSmithKline: рыночная капитализация + чистый долг (EV для GlaxoSmithKline), £
GlaxoSmithKline. Market cap, changes, %
GlaxoSmithKline (GSK) Market cap US GAAP (quarter values) |
||||||||
| 2024Q2 | 2024Q1 | 2024Q3 | 2024Q2 | 2024Q3 | LTM ? | |||
| Market cap, £ | 78 520 750 000 | 87 219 015 000 | 83 395 200 000 | 157 041 500 000 | 83 395 200 000 | 69 870 000 000 | ||
| Changes by years, y/y, % | -46% | -39% | +13% | +9% | +13% | |||
| Changes by quarters, q/q, % | -48% | +11% | -4% | +88% | -47% | |||
